Daily Markets: Omicron Vaccine Concerns Weigh on Equities

Rnewed Omicron concerns followed comments by Moderna (MRNA) CEO Stephane Bancel, who told the Financial Times he expects existing vaccines to be less effective against the new variant.

Read More

Leave a Reply

%d bloggers like this: